 |
|
|
| |
Second-Generation HIV-1 Maturation Inhibitor BMS-955176: Antiviral Activity and Safety with Atazanavir ± Ritonavir
|
| |
| |
Reported by Jules Levin
IAS 2015, July 19-22, 2015, Vancouver
8th Conference on HIV Pathogenesis, Treatment and Prevention. July 19-22, 2015
Carey Hwang,1 Dirk Schurmann,2 Christian Sobotha,2 Marta Boffito,3 Heather Sevinsky,1 Neelanjana Ray,1 Palanikumar Ravindran,1 Hong Xiao,1 Mark Krystal,4 Ira Dicker,4 Dennis Grasela,1 and Max Lataillade,4
on behalf of the BMS HIV Global Development Team
1Bristol-Myers Squibb, Research and Development, Princeton, NJ, USA
2Charite Research Organisation GmbH, Chariteplatz 1, 10117 Berlin, Germany
3St. Stephen's Centre, Chelsea and Westminster Hospital, London, UK
4Bristol-Myers Squibb, Research and Development, Wallingford, CT, USA
|
| |
|
|
|
|
|
